BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 176 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2020. The put-call ratio across all filers is 0.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $3,212,000 | -73.8% | 47,000 | -67.1% | 0.28% | -70.9% |
| Q4 2020 | $12,257,000 | +46.7% | 143,000 | +11.3% | 0.96% | +40.4% |
| Q3 2020 | $8,354,000 | -21.5% | 128,500 | -11.7% | 0.68% | -50.3% |
| Q2 2020 | $10,638,000 | +322.5% | 145,500 | +96.6% | 1.38% | +184.7% |
| Q1 2020 | $2,518,000 | -45.6% | 74,000 | -12.9% | 0.48% | -46.0% |
| Q4 2019 | $4,628,000 | +46.0% | 85,000 | +11.8% | 0.89% | +34.0% |
| Q3 2019 | $3,170,000 | -35.9% | 76,000 | -32.7% | 0.67% | -31.3% |
| Q2 2019 | $4,943,000 | +35.2% | 112,893 | +59.0% | 0.97% | +30.7% |
| Q1 2019 | $3,655,000 | +23.3% | 71,000 | -5.3% | 0.74% | +30.4% |
| Q2 2018 | $2,964,000 | – | 75,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |